Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-11 | ARS Pharmaceuticals, Inc. | Deerfield Private...
(AtLeastTenPercentOwner) |
S | Class A Common Stock | D | 563270 | $17.16 - $18.15 | $10,143,701 |
2024-10-08 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $13.83 - $13.83 | $1,382,775 |
2024-10-08 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $13.83 - $13.83 | $1,382,775 |
2024-09-17 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $12.93 - $12.93 | $1,293,205 |
2024-09-10 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $11.50 - $11.50 | $1,149,775 |
2024-09-10 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $11.50 - $11.50 | $1,149,775 |
2024-08-26 | ARS Pharmaceuticals, Inc. | ORBIMED CAPITAL LLC
(Director) |
S | Common Stock | D | 83695 | $13.00 - $13.00 | $1,088,035 |
2024-08-21 | ARS Pharmaceuticals, Inc. | Thompson Peter A.
(Director) |
S | Common Stock | D | 868682 | $12.94 - $14.61 | $11,497,963 |
2024-08-21 | ARS Pharmaceuticals, Inc. | ORBIMED CAPITAL LLC
(Director) |
S | Common Stock | D | 868682 | $12.94 - $14.61 | $11,497,963 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Dorsey Brian
(Chief Operating Officer) |
S | Common Stock | D | 50000 | $15.00 - $15.00 | $750,000 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Dorsey Brian
(Chief Operating Officer) |
M | Common Stock | A | 50000 | $0.64 - $0.64 | $32,000 |
2024-08-19 | ARS Pharmaceuticals, Inc. | Karas Eric
(Chief Commercial Officer) |
S | Common Stock | D | 10000 | $14.00 - $14.00 | $140,000 |
2024-08-19 | ARS Pharmaceuticals, Inc. | Karas Eric
(Chief Commercial Officer) |
M | Common Stock | A | 10000 | $1.50 - $1.50 | $15,000 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Scott Kathleen D.
(Chief Financial Officer) |
S | Common Stock | D | 12500 | $16.00 - $16.00 | $200,000 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Scott Kathleen D.
(Chief Financial Officer) |
M | Common Stock | A | 12500 | $1.50 - $1.50 | $18,750 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $14.76 - $16.26 | $1,502,584 |
2024-08-20 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $14.76 - $16.26 | $1,502,584 |
2024-07-09 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $9.62 - $9.62 | $961,724 |
2024-07-09 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $9.62 - $9.62 | $961,724 |
2024-06-13 | ARS Pharmaceuticals, Inc. | Shah Pratik
(Director) |
G | Common Stock | D | 1332900 | $0.00 - $0.00 | $0 |
2024-06-07 | ARS Pharmaceuticals, Inc. | Shah Pratik
(Director) |
G | Common Stock | D | 1332950 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |